The medical imaging reagents market size has grown strongly in recent years. It will grow from $15.23 billion in 2024 to $16.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing prevalence of diseases, growing aging population, expanding applications, regulatory approvals, strategic collaborations and partnerships.
The medical imaging reagents market size is expected to see strong growth in the next few years. It will grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, increasing focus on early disease detection, rising global burden of chronic diseases, expanding point-of-care imaging, integration of theranostics. Major trends in the forecast period include technological advancements, increasing prevalence of chronic diseases, diagnostic imaging in personalized medicine, emerging markets and global expansion, partnerships and collaborations.
The growth of the medical imaging reagents market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, necessitate the use of medical imaging reagents for accurate diagnosis and detection. Notably, in 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States. Additionally, the IDF Diabetes Atlas Tenth Edition 2021 revealed that 537 million individuals aged 20 to 79 years had diabetes in 2021, a figure expected to rise to 643 million by 2030 and 783 million by 2045. This surge in chronic diseases is a driving force behind the growth of the medical imaging reagents market.
The medical imaging reagents market is also set to witness growth due to the increasing demand in the pharmaceutical industry. Playing a crucial role in research, drug development, and precision medicine, medical imaging reagents contribute significantly to advancing pharmaceutical endeavors. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported a total pharmaceutical production of $384.2 billion (€340,000 million) in Europe in 2022, reflecting a 4.95% increase from the previous year. This heightened demand in pharmaceutical industries is a key factor fueling the growth of the medical imaging reagents market.
A prominent trend in the medical imaging reagents market is the emphasis on product innovations by major companies to maintain their competitive positions. Notably, Aptamer Group plc, a UK-based company, introduced Optimer-Fc in March 2023. Optimer-Fc combines an Optimer binder with an antibody's Fc domain, enabling its use in IHC applications. This innovative reagent facilitates enhanced research, diagnostics, and forensics, offering improved precision and selectivity in detection.
Leading companies in the medical imaging reagents market are concentrating on creating innovative products, such as the cell painting kit, to boost their revenues. This kit features pre-optimized, verified fluorescent probes along with a compatible diluent, designed to streamline the cell painting workflow while ensuring excellent repeatability and validation for use in high-content screening systems. For example, in December 2023, Amazon Web Services (AWS), a US-based company, is revolutionizing drug discovery through high-throughput Cell Painting, an advanced image-based assay for high-content screening. This method enhances the understanding of cellular behaviors and phenotypes. By leveraging AWS's scalable infrastructure, researchers can effectively manage large volumes of cell image data and execute complex image processing tasks. The Cell Painting Batch solution on AWS, utilizing tools like CellProfiler, automates these processes and addresses challenges such as fluctuating workloads, collaboration hurdles, and high computational requirements. This approach accelerates drug discovery while also improving scientific reproducibility and fostering collaboration across laboratories.
In December 2023, Mindray, a multinational medical technology company based in China that specializes in developing and manufacturing medical equipment and accessories, acquired DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition enhances Mindray's global supply chain and broadens its in-vitro diagnostics (IVD) business. DiaSys Diagnostic Systems GmbH, located in Germany, focuses on creating diagnostic system solutions, including automated clinical chemistry analyzers, semi-automated analyzers, and point-of-care instruments.
Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires André Guerbet, Canon Medical Systems Corporation, Fujifilm Healthcare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation.
North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Medical imaging reagents are substances utilized by medical practitioners and researchers to enhance the visibility of structures and organs, aiding in the identification, diagnosis, and treatment of diseases. They play a crucial role in visualizing structures or organs, allowing clinicians to improve disease identification and diagnosis.
The main classes of medical imaging reagents include contrast reagents, optical reagents, and nuclear reagents. Contrast agents specifically enhance radiodensity and increase the contrast of structures or fluids in medical imaging by altering the way electromagnetic radiation or ultrasound waves pass through the body. Various technologies involved in these reagents include nanoparticles, fluorescent dyes, radiopharmaceuticals, fluorescent proteins, and quantum dots. These technologies are applied in various imaging modes such as X-ray, CT scan, ultrasound, and MRI scan. Medical imaging reagents find applications in diverse medical conditions, including neurological disorders, cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, nephrological disorders, and others. These reagents are used by various end-users, including biotechnology companies, pharmaceutical companies, and diagnostic labs.
The medical imaging reagents market research report is one of a series of new reports that provides medical imaging reagents market statistics, including medical imaging reagents industry global market size, regional shares, competitors with a medical imaging reagents market share, detailed medical imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the medical imaging reagents industry. This medical imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical imaging reagents market consists of sales of fluorescent visualizing reagents, supermolecules, and magnetic resonance imaging reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The medical imaging reagents market size is expected to see strong growth in the next few years. It will grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, increasing focus on early disease detection, rising global burden of chronic diseases, expanding point-of-care imaging, integration of theranostics. Major trends in the forecast period include technological advancements, increasing prevalence of chronic diseases, diagnostic imaging in personalized medicine, emerging markets and global expansion, partnerships and collaborations.
The growth of the medical imaging reagents market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, necessitate the use of medical imaging reagents for accurate diagnosis and detection. Notably, in 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States. Additionally, the IDF Diabetes Atlas Tenth Edition 2021 revealed that 537 million individuals aged 20 to 79 years had diabetes in 2021, a figure expected to rise to 643 million by 2030 and 783 million by 2045. This surge in chronic diseases is a driving force behind the growth of the medical imaging reagents market.
The medical imaging reagents market is also set to witness growth due to the increasing demand in the pharmaceutical industry. Playing a crucial role in research, drug development, and precision medicine, medical imaging reagents contribute significantly to advancing pharmaceutical endeavors. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported a total pharmaceutical production of $384.2 billion (€340,000 million) in Europe in 2022, reflecting a 4.95% increase from the previous year. This heightened demand in pharmaceutical industries is a key factor fueling the growth of the medical imaging reagents market.
A prominent trend in the medical imaging reagents market is the emphasis on product innovations by major companies to maintain their competitive positions. Notably, Aptamer Group plc, a UK-based company, introduced Optimer-Fc in March 2023. Optimer-Fc combines an Optimer binder with an antibody's Fc domain, enabling its use in IHC applications. This innovative reagent facilitates enhanced research, diagnostics, and forensics, offering improved precision and selectivity in detection.
Leading companies in the medical imaging reagents market are concentrating on creating innovative products, such as the cell painting kit, to boost their revenues. This kit features pre-optimized, verified fluorescent probes along with a compatible diluent, designed to streamline the cell painting workflow while ensuring excellent repeatability and validation for use in high-content screening systems. For example, in December 2023, Amazon Web Services (AWS), a US-based company, is revolutionizing drug discovery through high-throughput Cell Painting, an advanced image-based assay for high-content screening. This method enhances the understanding of cellular behaviors and phenotypes. By leveraging AWS's scalable infrastructure, researchers can effectively manage large volumes of cell image data and execute complex image processing tasks. The Cell Painting Batch solution on AWS, utilizing tools like CellProfiler, automates these processes and addresses challenges such as fluctuating workloads, collaboration hurdles, and high computational requirements. This approach accelerates drug discovery while also improving scientific reproducibility and fostering collaboration across laboratories.
In December 2023, Mindray, a multinational medical technology company based in China that specializes in developing and manufacturing medical equipment and accessories, acquired DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition enhances Mindray's global supply chain and broadens its in-vitro diagnostics (IVD) business. DiaSys Diagnostic Systems GmbH, located in Germany, focuses on creating diagnostic system solutions, including automated clinical chemistry analyzers, semi-automated analyzers, and point-of-care instruments.
Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires André Guerbet, Canon Medical Systems Corporation, Fujifilm Healthcare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation.
North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Medical imaging reagents are substances utilized by medical practitioners and researchers to enhance the visibility of structures and organs, aiding in the identification, diagnosis, and treatment of diseases. They play a crucial role in visualizing structures or organs, allowing clinicians to improve disease identification and diagnosis.
The main classes of medical imaging reagents include contrast reagents, optical reagents, and nuclear reagents. Contrast agents specifically enhance radiodensity and increase the contrast of structures or fluids in medical imaging by altering the way electromagnetic radiation or ultrasound waves pass through the body. Various technologies involved in these reagents include nanoparticles, fluorescent dyes, radiopharmaceuticals, fluorescent proteins, and quantum dots. These technologies are applied in various imaging modes such as X-ray, CT scan, ultrasound, and MRI scan. Medical imaging reagents find applications in diverse medical conditions, including neurological disorders, cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, nephrological disorders, and others. These reagents are used by various end-users, including biotechnology companies, pharmaceutical companies, and diagnostic labs.
The medical imaging reagents market research report is one of a series of new reports that provides medical imaging reagents market statistics, including medical imaging reagents industry global market size, regional shares, competitors with a medical imaging reagents market share, detailed medical imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the medical imaging reagents industry. This medical imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical imaging reagents market consists of sales of fluorescent visualizing reagents, supermolecules, and magnetic resonance imaging reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Medical Imaging Reagents Market Characteristics3. Medical Imaging Reagents Market Trends and Strategies4. Medical Imaging Reagents Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Medical Imaging Reagents Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Medical Imaging Reagents Market34. Recent Developments in the Medical Imaging Reagents Market
5. Global Medical Imaging Reagents Growth Analysis and Strategic Analysis Framework
6. Medical Imaging Reagents Market Segmentation
7. Medical Imaging Reagents Market Regional and Country Analysis
8. Asia-Pacific Medical Imaging Reagents Market
9. China Medical Imaging Reagents Market
10. India Medical Imaging Reagents Market
11. Japan Medical Imaging Reagents Market
12. Australia Medical Imaging Reagents Market
13. Indonesia Medical Imaging Reagents Market
14. South Korea Medical Imaging Reagents Market
15. Western Europe Medical Imaging Reagents Market
16. UK Medical Imaging Reagents Market
17. Germany Medical Imaging Reagents Market
18. France Medical Imaging Reagents Market
19. Italy Medical Imaging Reagents Market
20. Spain Medical Imaging Reagents Market
21. Eastern Europe Medical Imaging Reagents Market
22. Russia Medical Imaging Reagents Market
23. North America Medical Imaging Reagents Market
24. USA Medical Imaging Reagents Market
25. Canada Medical Imaging Reagents Market
26. South America Medical Imaging Reagents Market
27. Brazil Medical Imaging Reagents Market
28. Middle East Medical Imaging Reagents Market
29. Africa Medical Imaging Reagents Market
30. Medical Imaging Reagents Market Competitive Landscape and Company Profiles
31. Medical Imaging Reagents Market Other Major and Innovative Companies
35. Medical Imaging Reagents Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Medical Imaging Reagents Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on medical imaging reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical imaging reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical imaging reagents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Class: Contrast Reagents; Optical Reagents; Nuclear Reagents2) by Technology: Nanoparticles; Fluorescent Dyes; Probes Radiopharmaceuticals; Fluorescent Proteins; Quantum Dots
3) by Modality: X-ray; CT Scan; Ultrasound; MRI Scan
4) by Application: Neurological Disorder; Cardiovascular Disorder; Cancer; Gastrointestinal Disorder; Musculoskeletal Disorder; Nephrological Disorder; Other Applications
5) by End User: Biotechnology Companies; Pharmaceutical Companies; Diagnostic Labs
Subsegments:
1) by Contrast Reagents: Iodine-Based Contrast Agents; Barium Sulfate Contrast Agents; Gadolinium-Based Contrast Agents2) by Optical Reagents: Fluorescent Dyes; Luminescent Agents; Optical Probes
3) by Nuclear Reagents: Radioisotopes; Radiopharmaceuticals
Key Companies Mentioned: General Electric Company; Lantheus Holdings Inc.; Thermo Fisher Scientific Inc.; Bayer AG; Bracco SpA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Medical Imaging Reagents market report include:- General Electric Company
- Lantheus Holdings Inc.
- Thermo Fisher Scientific Inc.
- Bayer AG
- Bracco SpA
- Siemens AG
- PerkinElmer Inc.
- Cardinal Health Inc.
- Shimadzu Corporation
- Philips Healthcare
- SA Laboratoires André Guerbet
- Canon Medical Systems Corporation
- Fujifilm Healthcare
- Guerbet Group
- Merck KGaA
- Esaote SpA
- Hitachi Ltd.
- Koninklijke Philips N.V.
- Toshiba Corporation
- Hologic Inc.
- Carestream Health Inc.
- Curium Pharma
- Nordion Inc.
- IBA Molecular
- Eckert & Ziegler Radiopharma GmbH
- Advanced Accelerator Applications
- Jubilant Life Sciences Limited
- Mallinckrodt Pharmaceuticals
- Nihon Kohden Corporation
- Mindray Medical International Limited
- Samsung Medison Co. Ltd.
- Analogic Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 16.31 Billion |
| Forecasted Market Value ( USD | $ 21.31 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
